Integra LifeSciences Amends Officer & Director Changes Filing
Ticker: IART · Form: 8-K/A · Filed: Feb 27, 2024 · CIK: 917520
| Field | Detail |
|---|---|
| Company | Integra Lifesciences Holdings Corp (IART) |
| Form Type | 8-K/A |
| Filed Date | Feb 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, amendment, compensation
TL;DR
🚨 **Integra LifeSciences filed an 8-K/A on Feb 27, 2024, amending a Dec 12, 2023 report on officer/director changes and compensation.**
AI Summary
Integra LifeSciences Holdings Corp. filed an 8-K/A amendment on February 27, 2024, pertaining to an event that occurred on December 12, 2023. The filing addresses the departure, election, or appointment of certain directors or officers, and related compensatory arrangements. No specific names or dollar amounts were detailed in the provided text.
Why It Matters
Changes in leadership and executive compensation can signal strategic shifts or operational adjustments within Integra LifeSciences, potentially impacting future company direction and performance.
Risk Assessment
Risk Level: medium — The filing is an amendment regarding officer/director changes and compensation, which is a routine disclosure, and the provided text lacks specific details to indicate a higher or lower risk.
Key Players & Entities
- INTEGRA LIFESCIENCES HOLDINGS CORP (company) — Registrant
- December 12, 2023 (date) — Date of earliest event reported
- February 27, 2024 (date) — Filed as of date
FAQ
What type of SEC filing is this document?
This document is an 8-K/A, which is an amendment (Amendment No. 1) to a Current Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the name of the registrant company?
The registrant company is INTEGRA LIFESCIENCES HOLDINGS CORP ORATION.
What was the date of the earliest event reported in this filing?
The date of the earliest event reported was December 12, 2023.
What specific items of information are covered by this 8-K/A filing?
The filing covers Item Information related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
When was this 8-K/A filing filed with the SEC?
This 8-K/A filing was filed as of February 27, 2024.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-02-27 17:15:18
Filing Documents
- iart-20231212.htm (8-K/A) — 22KB
- 0000917520-24-000011.txt ( ) — 172KB
- iart-20231212.xsd (EX-101.SCH) — 2KB
- iart-20231212_def.xml (EX-101.DEF) — 14KB
- iart-20231212_lab.xml (EX-101.LAB) — 27KB
- iart-20231212_pre.xml (EX-101.PRE) — 15KB
- iart-20231212_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INTEGRA LIFESCIENCES HOLDINGS CORPORATION Date: February 27, 2024 By: /s/ Eric I. Schwartz Eric I. Schwartz Title: Executive Vice President, Chief Legal Officer and Secretary